Unknown

Dataset Information

Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients.


ABSTRACT:

Background

Lymphomas are characterized by elevated synthesis of inflammatory soluble mediators that could trigger the development of venous thromboembolism (VTE). However, data on the relationship between specific immune dysregulation and VTE occurrence in patients with lymphoma are scarce. Therefore, this study aimed to assess the association between inflammatory markers and the risk of VTE development in patients with lymphoma.

Methods

The erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lactate dehydrogenase (LDH), total protein (TP), and albumin were assessed in 706 patients with newly diagnosed or relapsed lymphoma. Data were collected for all VTE events, while the diagnosis of VTE

SUBMITTER: Otasevic V 

PROVIDER: S-EPMC9016935 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature